With the development of the global epidemic, Chinese medicine varieties such as radix isatidis and honeysuckle are in short supply in many countries.

"In the early stage of the outbreak in China, the prices of many medicinal materials, such as honeysuckle and forsythia, rose." A Chinese medicine personage introduces to the reporter, with the outbreak of the global epidemic, the overseas Chinese medicine demand becomes its price trend important influence factor.

However, lu zhenyu, a doctor of traditional Chinese medicine at the tianshan hospital of traditional Chinese medicine in Shanghai, told reporters that one of the challenges is the shortage of traditional Chinese medicine doctors. "The use and compatibility of Chinese medicinal materials must be carried out by professional doctors."

In addition, a doctor who asked not to be named told reporters that although acupuncture and massage services are recognized overseas, traditional Chinese medicine is subject to a large policy barrier such as drug approval, so it will take time to spread traditional Chinese medicine in a world wide way. "The outbreak may be a catalyst, but there are challenges to making a real difference."

Under the epidemic situation, the export of Chinese medicinal materials was increased

With the stability of the epidemic situation in China, the role of traditional Chinese medicine in the fight against the epidemic has attracted attention. A group of traditional Chinese medicine, represented by jinhua qinggan granules, lianhua qingwen capsules, xue bijing injection and qingfei detoxification soup, hua shi fudu prescription and "three drugs and three parties", has been proved to have obvious curative effects. As the global epidemic develops, relevant Chinese organizations and institutions have donated medicines and instruments such as proprietary Chinese medicines, decoction pieces and acupuncture needles to Italy, France and other countries, as well as to Hong Kong and Macao.

According to media reports, in the first two months of this year, anhui province exported 3,357 tons of traditional Chinese medicine, worth 120 million yuan, up 7.3% and 7.1% year-on-year, 12.3 percentage points and 6.3 percentage points higher than the growth rate of the country's traditional Chinese medicine exports in the same period.

In the traditional export market of traditional Chinese medicinal materials, the export to South Korea was 45,456,000 yuan, which was basically the same as in previous years. Exports to asean and Taiwan reached 35.88 million yuan and 24.164 million yuan, up 88.6% and 31.1%, respectively. In addition, the export of Chinese medicinal materials to Europe reached 2.665 million yuan, up 48.6%, among which the export to Spain, Russia, Hungary, Albania and other countries achieved a breakthrough of zero compared with that in 2019.

However, in the industry's view, the export of traditional Chinese medicine is only the first step. One of the key challenges facing the internationalization of traditional Chinese medicine, lu said, is the uneven level of TCM. "At present, there is no sound evaluation system for TCM, which also leads to the personalized and differentiated diagnosis and treatment cannot be applied to the first-line treatment of major diseases in the first time. "The situation also faces the same challenges in foreign countries, and each country has different barriers to entry for TCM."

Many listed companies export their products overseas

According to the reporter comb, A share of listed Chinese medicine companies to join the team of Chinese medicine.

Li anping, chairman of zhendong pharmaceutical co., LTD., introduced to the reporter that the company exported a variety of products and diversified businesses: to Mongolia, Indonesia, Australia and China's Taiwan region exported nearly 10 million yuan of Chinese medicinal materials and yinpian; With the United States, Italy, Spain and other affected areas are negotiating the export of epidemic prevention materials. In terms of international cooperation, the Middle East countries have an increasingly strong demand for traditional Chinese medicine. Recently, the ambassador of the embassy of Iraq also visited the company for exchange and cooperation on traditional Chinese medicine projects. Vietnam's drug registration work is also in full swing, orderly development.

The company said on its investor platform that it has received international orders and is actively organizing the export of proprietary Chinese medicines and masks.

China resources sanjiu co., ltd. said that with the covid-19 epidemic under effective control in China and the increasingly severe epidemic situation in overseas countries, the company has been studying the opportunities of expanding the overseas market for varieties such as traditional Chinese medicine granule.

It is worth mentioning that, with the sudden increase in the demand to fight the epidemic, since January this year, the prices of some Chinese medicinal materials have also risen.

"Whether subsequent prices are strong depends on whether traditional Chinese medicine can play a bigger role in the global outbreak." An industry figure told reporters, however, this is still more difficult.

The impact on the performance of listed companies varies

Although traditional Chinese medicine (TCM) has received much attention in the fight against the epidemic, the data show that the degree of benefits for enterprises in the industry varies.

As of April 13, A total of 13 listed Chinese medicine companies released earnings forecasts, according to data from the company. Among them, 3 companies are expected to show a slight decrease in performance, 1 listed company shows a loss in performance, 4 companies are expected to show a decrease in performance, 2 companies are expected to show a slight increase in performance, and 3 companies are expected to show a slight increase in performance.

Huahua pharmaceutical expects the first quarter of this year's performance to achieve double growth. Huahua pharmaceutical said that the company is currently in the production of national epidemic recommended drugs and antipyretic and detoxifying drugs mainly for fangfengtongsheng pills, juhong pear paste, etc., the company in the premise of good protection under the organization of overtime production of such drugs, for the first quarter sales revenue contributed to a new growth point.